Labshake search
Citations for Tocris :
1 - 50 of 95 citations for Kanamycin kinase type II NEO Klebsiella pneumoniae since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2021Quote: ... namely the mitogen activated protein kinase kinase (MAPKK) inhibitor U0126 (50 μM) and the CaM kinase II (CaMKII) inhibitor KN-62 (10 μM) (Tocris Bioscience, United Kingdom). The inhibitors were added to the cultures thirty minutes prior to DOI treatment ...
-
bioRxiv - Cell Biology 2020Quote: ... Rho-kinase inhibitor (Tocris) was added to single cell dissociated organoids ...
-
bioRxiv - Pharmacology and Toxicology 2022Quote: Kinase inhibitors were purchased from Tocris (www.tocris.com), Selleck Chemicals (www.selleckchem.com) ...
-
bioRxiv - Cell Biology 2022Quote: The mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor U0126 and the p38 MAPK inhibitor SB203580 were purchased from Tocris Bioscience (Bristol ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of PI3-Kinase (Wortmanin, 100 nM, Tocris), inhibitor of p38 MAP kinase (SB203580 ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of p38 MAP kinase (SB203580, 10 μM, Tocris), inhibitor of ERK MAP kinase (PD90859 ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of ERK MAP kinase (PD90859, 10 μM, Tocris), inhibitor of Cdc42 (ML141 ...
-
bioRxiv - Genetics 2023Quote: ... 10μM Y-27632 Rho-kinase inhibitor (ROCKi; Tocris #1254) was added to culture media ...
-
bioRxiv - Developmental Biology 2020Quote: ... and 10 μM ALK4/5/7 kinase inhibitor SB431542 (Tocris) at 37 °C in 5% CO2 ...
-
bioRxiv - Cell Biology 2022Quote: ... Stocks of the kinase inhibitor MLi-2 (10 mM; Tocris) were stored in DMSO at −20°C.
-
bioRxiv - Neuroscience 2021Quote: ... coiled-coil containing protein kinase (ROCK1/2) Y27632 (Tocris, Inc.) at 10 µM in PBS for 1-2 hr ...
-
bioRxiv - Cancer Biology 2022Quote: ... 25 μM ML-7 (Tocris, myosin light-chain kinase inhibitor), 500 μM carbenoxolone (Sigma ...
-
bioRxiv - Neuroscience 2022Quote: ... and 10μM Y-27632 dihydrochloride (Rho kinase ROCK inhibitor) (Tocris) from day 20 for the whole duration of terminal differentiation ...
-
bioRxiv - Biophysics 2023Quote: Stocks of the kinase inhibitors MLi-2 (10 mM; Tocris) and GZD-824 (10 mM ...
-
bioRxiv - Neuroscience 2024Quote: ... and 10μM Y-27632 dihydrochloride (Rho kinase ROCK inhibitor) (Tocris) from day 20 for the whole duration of terminal differentiation ...
-
bioRxiv - Bioengineering 2024Quote: ... 10 μM Rho kinase inhibitor (RI, Y-27632) (Tocris, 1254) was used ...
-
bioRxiv - Developmental Biology 2022Quote: ... Media containing Src-kinase inhibitor (10μM PP2; Tocris Bioscience; Cat #1407) and/or FGF8b (100ng/ml ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with Rho Kinase Inhibitor (Y-27632, 10 µM, Tocris, 1254) (Day 0) ...
-
bioRxiv - Bioengineering 2022Quote: ... supplemented with Rho Kinase Inhibitor (Y-27632, 10 µM, Tocris, 1254) (day 0) ...
-
bioRxiv - Bioengineering 2023Quote: ... Rho-associated protein kinase (ROCK) (Y-27632, 25 µM, Tocris, UK), or phosphoinositide 3-kinase (PI3K ...
-
bioRxiv - Bioengineering 2023Quote: ... or phosphoinositide 3-kinase (PI3K) (LY 294002, 10 µM, Tocris, UK) for 4 days ...
-
bioRxiv - Neuroscience 2022Quote: Pharmacological compounds were obtained from the following sources: Rho Kinase Inhibitor (Tocris). Retinoic Acid (Sigma) ...
-
bioRxiv - Developmental Biology 2022Quote: ... 10 μM Rho-associated protein kinase (ROCK) inhibitor Y-27632 (Tocris, 1254) was added to the culture medium for 24 hours.
-
bioRxiv - Neuroscience 2019Quote: The brain penetrant and orally bioavailable p21-activated kinase (PAK) inhibitor FRAX486 (Tocris, 5190) was used to inhibit PAK1-4 in pharmacological inhibition/rescue experiments ...
-
bioRxiv - Neuroscience 2021Quote: We inhibited LRRK2 kinase activity with the selective LRRK2 inhibitor MLi-2 (Tocris 5756). MLi-2 has low solubility in water ...
-
bioRxiv - Cancer Biology 2023Quote: ... a selection p38 MAP kinase inhibitor and 10 nM nicotinamide (Tocris Bioscience, Bristol, UK) for the first day of passaging to prevent anoikis ...
-
bioRxiv - Cell Biology 2023Quote: ... The medium was supplemented with 10 μM Rho kinase (ROCK) inhibitor Y-27632 (ROCKi, Tocris) for the first 24 h after passaging.
-
bioRxiv - Genetics 2023Quote: ... When thawing KOLF2.1Js 10 µM Rho-associated protein kinase (ROCK) inhibitor (Y-27632) (Tocris, #1254) was added into the culture media overnight.
-
bioRxiv - Bioengineering 2023Quote: ... or pharmacological inhibitors of focal adhesion kinase (FAK) (FAK inhibitor 14, 5 µM, Tocris, UK), Rho-associated protein kinase (ROCK ...
-
bioRxiv - Developmental Biology 2024Quote: ... The medium was supplemented with Rho-associated protein kinase (ROCK) inhibitor Y-27632(Tocris, 1254) at a final concentration of 10 µM for the first 24h after passaging ...
-
bioRxiv - Molecular Biology 2022Quote: ... cells were plated in StemFlex media supplemented with 10uM Y-27632 rho kinase inhibitor (Tocris, 1254). Genomic DNA extraction was performed 72 hours after transfection ...
-
bioRxiv - Cancer Biology 2020Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2021Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 μM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Cancer Biology 2022Quote: ... TGF-ß type I receptor inhibitor A83-01 (Tocris), P38 inhibitor SB202190 (Sigma-Aldrich) ...
-
bioRxiv - Neuroscience 2023Quote: ... Type I mGluR agonist DHPG (Tocris, 0805; 100 µM) was dissolved in HEPES-aCSF in the presence of non-mGluR glutamate receptor blockers (CNQX ...
-
bioRxiv - Neuroscience 2019Quote: ... LY341495 (group II mGluR; Tocris), MK-801 (NMDA receptors ...
-
bioRxiv - Neuroscience 2020Quote: ... angiotensin II (Tocris, Bristol, UK), or human ACE2 (R&D ...
-
bioRxiv - Cell Biology 2021Quote: H9 hESCs were treated with 10 µM Rho-associated protein kinase inhibitor (ROCKi, Tocris Bioscience #Y-27632) for 24 h before they were dissociated to single cells and pelleted ...
-
bioRxiv - Cell Biology 2020Quote: ... The Src-family kinases inhibitor PP2 and Syk inhibitor PRT-060318 were purchased from TOCRIS (Abingdon, UK) and Caltag Medsystems (Buckingham ...
-
bioRxiv - Physiology 2022Quote: Tissue was homogenized in 1X PBS and 200 nM adenosine kinase inhibitor ABT 702 dihydrochloride (Tocris Bioscience) at a concentration of 100 mg tissue/ 1 mL PBS ...
-
bioRxiv - Bioengineering 2024Quote: ... and cultured using mTESRTM Plus medium supplemented with 10 µM Y27632 Rho-kinase (ROCK) inhibitor (Tocris; 1254). After 24 hours of culture ...
-
bioRxiv - Bioengineering 2024Quote: ... and cultured using mTESRTM Plus medium supplemented with 10 µM Y27632 Rho-kinase (ROCK) inhibitor (Tocris; 1254). After 24 hours of culture ...
-
bioRxiv - Bioengineering 2019Quote: ... TGF-β type I receptor inhibitor A83-01 500nM (Tocris), P38 inhibitor SB202190 10μM(Sigma-Aldrich) ...
-
bioRxiv - Cell Biology 2021Quote: ... and 30 µM SKI-II (Tocris). All inhibitors were dissolved in DMSO and diluted to 10x concentration in OptiMEM ...
-
bioRxiv - Molecular Biology 2023Quote: ... Ang II (4474-91-3, Tocris) was injected subcutaneously at a total dose of 1 ...
-
bioRxiv - Developmental Biology 2021Quote: ... the medium was complemented by addition of the Rho kinase inhibitor Y-27632 (10mM, Tocris, Cat. No. 1254). HPSC quality control and passage number information are provided as metadata.
-
bioRxiv - Neuroscience 2021Quote: ... cells were passaged with the p160-Rho-associated coiled-coil kinase (ROCK) inhibitor Y-27632 (10 μM; Tocris) or RevitaCell™ Supplement (ThermoFisher scientific ...
-
bioRxiv - Cell Biology 2021Quote: ... interleukin-1 receptor-associated kinase 1 and 4 (IRAK 1/4; IRAK 1/4 inhibitor, 0.1 μM; Tocris); TANK-binding kinase 1 (TBK1 ...
-
bioRxiv - Biochemistry 2021Quote: ... cells were treated with either DMSO or 1 µM of LRRK2 kinase inhibitor (MLi-2, cat.no. 5756, TOCRIS) for 90 mins and then examined for localization ...
-
bioRxiv - Cell Biology 2023Quote: ... to create a single cell suspension prior to resuspension in TeSR medium supplemented with ROCK kinase inhibitor (Tocris 1254 ...